American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push 
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex 
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers 
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 
Toyota Retains Global Auto Sales Crown in 2025 With Record 11.3 Million Vehicles Sold 
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
DUBLIN, Ireland, May 25, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has been selected to Fortune’s “Best Workplaces in Chicago” list. Horizon ranked number two on the list of the best small and medium-sized companies.
“It’s a great honor to be recognized by Fortune as one of its Best Workplaces in Chicago,” said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. “At Horizon, we know our employees are our most important asset and we work hard to provide an enriching environment where our whole team feels valued and empowered to create change.”
Horizon received this recognition based on employees' anonymous responses to an extensive survey about their camaraderie, professional development and sense of purpose at work. Great Place to Work® reviewed the survey results of more than 81,000 employees in the Chicago area.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
About the Best Workplaces in Chicago
Rankings are based on feedback from more than 81,000 employees at Great Place to Work–Certified organizations with locations in the Chicago area. An anonymous Trust Index© survey assessed their camaraderie, management, professional development, sense of purpose and other elements essential for an outstanding workplace. Scores also consider the complexity of organizations’ employee populations and how much of their business is located in the Chicago area.
About Great Place to Work®
Great Place to Work is the global authority on high-trust, high-performance workplace cultures. Through its certification programs, Great Place to Work recognizes outstanding workplace cultures and produces the annual Fortune "100 Best Companies to Work For®" and Great Place to Work Best Workplaces lists for Millennials, Women, Diversity, Small and Medium Companies, industries, and internationally, countries and regions. Through its culture consulting services, Great Place to Work helps clients create great workplaces that outpace peers on key business metrics like revenue growth, profitability, retention and stock performance. Follow Great Place to Work at www.greatplacetowork.com and on Twitter at @GPTW_US.
U.S. media contact: Geoff Curtis Senior Vice President, Corporate Affairs & Chief Communications Officer [email protected]
